Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Solacid is a marketed fixed-dose combination antacid and anti-flatulent medication developed and manufactured by Dey's Medical Stores. It contains dried aluminium hydroxide, magnesium hydroxide (milk of magnesia), magnesium trisilicate, and simethicone. The antacid components (aluminium hydroxide, magnesium hydroxide, and magnesium trisilicate) work locally in the stomach to neutralize excess gastric acid, thereby raising stomach pH and relieving symptoms of hyperacidity, heartburn, and indigestion. Simethicone acts as a surfactant that reduces the surface tension of gas bubbles in the gastrointestinal tract, facilitating their coalescence and expulsion to relieve bloating and flatulence. Solacid is available in oral tablet and liquid suspension formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Solacid.